WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022. A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used. Key moments from the arguments: |
China's weightlifting veteran Shi overcomes himselfHush money trial: Trump faces prospect of additional sanctions for violating gag orderJudge denies bail to teen charged with terrorThe Timberwolves' Mike Conley wins the NBA Teammate of the Year award for a 2nd timePSG, Barca set to renew Champions League rivalrySting and Stephen Fry threaten to resign from the Garrick Club unless women are allowed to joinBuilder finds creepy children's handprints on the back of Victorian roof tilesSting and Stephen Fry threaten to resign from the Garrick Club unless women are allowed to joinChris Sale tosses 5 strong innings, Braves avoid sweep with 5'Mumtrepeneur' opens a high